[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BPharmCatalyst BioPharmCatalyst

BioPharmCatalyst posts on X about $wint, $tnxp, $otlk, $bctx the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

X Week XXXXXX +46%
X Month XXXXXXX +51%
X Months XXXXXXX +48%
X Year XXXXXXXXX -XX%

Mentions: XX #

X Week XX +34%
X Month XX +8.50%
X Months XXX +29%
X Year XXX +71%

Followers: XXXXXX #

X Week XXXXXX +0.28%
X Month XXXXXX +0.80%
X Months XXXXXX +2%
X Year XXXXXX +4.20%

CreatorRank: XXXXXXX #

Social Influence #

Social category influence stocks XXXX% finance XXXX% cryptocurrencies XXXX%

Social topic influence $wint 2.52%, $tnxp 1.89%, $otlk 1.89%, $bctx 1.89%, $srpt 1.89%, $pmn 1.89%, $grph 1.26%, $vnda 1.26%, $fbio 1.26%, $rgnx XXXX%

Top accounts mentioned or mentioned by @marketwirenews @yusufhameed @jjnmeinlove @jewcypickle @ridgeviewtrim @oldnormanbates @amimami07683953 @stewdomer @dianegracely @financestrategi @voice4662 @terpstrader1 @gwandaraboy @dolemite

Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Cytokinetics Inc. (CYTK) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Arrowhead Research Corporation (ARWR) CRISPR Therapeutics AG (CRSP) Merck & Co., Inc. (MRK) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Zimmer Biomet Holdings Inc (ZBH) Johnson & Johnson (JNJ) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Bristol-Myers Squibb Co (BMY) Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) Vertex Protocol (VRTX) Parallax (PLX) GSK plc (GSK)

Top Social Posts #

Top posts by engagements in the last XX hours

"BioPharmCatalyst Weekly #Watchlist Key PDUFA and Regulatory Catalysts for the Next X Months $OMER $ABEO $RGNX $FBIO $CYTK $VNDA $OTLK $IONS $ARWR $TNXP $GRPH"
@BPharmCatalyst on X 2025-07-14 13:17:37 UTC 29.8K followers, 7191 engagements

"$MGRM will be acquired by $ZBH for $XXXX per share in cash totaling an equity value of $XXX million and an enterprise value of $XXX million. MGRM stockholders will also receive a non-tradeable contingent value right (CVR) of up to $XXXXX per share if product development regulatory and revenue milestones are met by 2030. See More Biotech Updates👇 $SONN $IPA $MGRM $DARE $BDRX $EPIX $DARE $SXTP"
@BPharmCatalyst on X 2025-07-14 20:43:02 UTC 29.8K followers, 2062 engagements

"🎧 New Episode Alert On Biotech Bulls and Breakthroughs John Gagliano and Sheff break down: 🔹 Key biotech market trends 🔹 Catalyst-driven trading strategies 🔹 Small-cap opportunities"
@BPharmCatalyst on X 2025-07-14 11:38:00 UTC 29.8K followers, 164.4K engagements

"Biotech updates 04/12: $BHVN buyout chatter +20% $TCON mid-stage fail -XX% $CLVS halts bladder trial -XX% $JNJ erdafitinib FDA approval $RNN reverse split $VTL - $IMUX Monday $BMY $CELG holders vote yes Pipeline updates $GLYC $HZNP $MNK $WVE"
@BPharmCatalyst on X 2019-04-13 00:09:18 UTC 29.8K followers, XX engagements

"Biotech updates 06/06 $LJPC data +92% $XERS PDUFA 3mth extension -XX% (-5% AH) $PLX Fabry BLA filing 1Q 2020 +35% $CRSP +10% (AH) DMD license with $VRTX $MTFB further trials reqd -XX% $JAGX r/split -XX% $INSY to pay $225m +33% $CELG ozanimod PDFUA 3/25"
@BPharmCatalyst on X 2019-06-07 00:06:29 UTC 29.8K followers, XX engagements

"BioPharmCatalyst Weekly #Watchlist Key Phase 1/2 catalyst for the next X months $CLLS $COGT $MRK $PMVP $GSK $MRSN $PEPG $ACIU $JSPR $CRSP $ENGN $JSPR $TIL"
@BPharmCatalyst on X 2025-07-05 15:00:01 UTC 29.8K followers, 4120 engagements

"$MRK will acquire $VRNA for $XXX per ADS in a deal valued at approximately $XX billion securing full ownership of Veronas respiratory drug assets. See More Pre-market Movers 👇 $KZIA $EVOK $PROK $ARTL $RXST $BCTX $BNTC $RYTM $ZVSA"
@BPharmCatalyst on X 2025-07-09 12:33:08 UTC 29.8K followers, 5733 engagements

"$EVOK received a USPTO Notice of Allowance for a patent covering GIMOTI use in moderate to severe gastroparesis expanding protection for its lead asset. See More Biotech Updates👇 $RXST $RYTM $BCTX $ZVSA $KZIA $VRNA $PROK"
@BPharmCatalyst on X 2025-07-09 20:19:57 UTC 29.8K followers, 5203 engagements

"$WINT signed a $60M securities purchase agreement led by Build and Build Corp with the potential to raise a total of $200M to launch a BNB crypto treasury strategy. Subject to shareholder approval Windtree aims to become the first NASDAQ-listed company offering direct BNB token exposure. See More Pre-market Movers 👇 $WINT $SRPT $PRTC $RCKT $NUWE"
@BPharmCatalyst on X 2025-07-17 12:23:48 UTC 29.8K followers, 4343 engagements

"$REVB announced that it will implement a 1-for-3 reverse stock split effective July X 2025 following shareholder approval. See More Pre-market Movers 👇 $TIL $PTHS $CYBN $NLSP $GNTA"
@BPharmCatalyst on X 2025-07-02 12:33:39 UTC 29.8K followers, 5314 engagements

"$XOMA announced that it has entered an agreement to acquire $KNTE for a base cash price of $XXXXXX per share and an additional cash amount of not more than $XXXXXX per share at the closing of the merger plus a non-transferable contingent value right (CVR) representing the right to receive XX% of the net proceeds from any out license or sale of the Kinnate programs effected within one year of closing of the merger or XXX% of the net proceeds from any out license or sale executed prior to the closing. $IVA $SGMO $MODD $SRPT $BRNS $BLRX $TTOO $IINN See More Pre-market Movers 👇"
@BPharmCatalyst on X 2024-02-16 13:14:27 UTC 29.8K followers, 2244 engagements

"$ITOS to be acquired by Concentra Biosciences for $10.047/share in cash plus a CVR tied to net cash above $475M and potential asset sales; tender offer to begin by Aug X 2025. See More Pre-market Movers 👇 $PMN $HSDT $ZIMV $SABS $NCNA $AUTL $EVO"
@BPharmCatalyst on X 2025-07-21 12:20:13 UTC 29.8K followers, 5956 engagements

"$NRXP shares traded higher after a Form X filing showed that director Jonathan C Javitt bought 100000 shares of the company at $XXXX per share. $SCTL $GRI $RVLP $KPRX $HOWL $SAVA $NRXP $MYO $YS Read more👇"
@BPharmCatalyst on X 2023-08-24 20:35:47 UTC 29.8K followers, 4257 engagements

"Biotech 6/10 $INSY BK -XX% $PRVB diabetes data +217% $RHHBY $SGEN DLBCL FDA approval $NBY +875% $GTXI-$ONCT $APTX +15% $SESN BLA 4Q -XX% $RHHBY $ONCE -X% delays $NVAX further trial reqd-12% Pipeline updates $ACHN $ADXS $ARPO $ARQL $BTAI $INNT $KZR $NVAX"
@BPharmCatalyst on X 2019-06-11 00:11:00 UTC 29.8K followers, XX engagements

"$CLSD initiated a strategic review to explore options including asset sales partnerships or M&A to advance its SCS platform; Piper Sandler retained to lead the process. See More Biotech Updates👇 $WINT $SRPT $RCKT $FOLD $MBRX $CLSD $ICU"
@BPharmCatalyst on X 2025-07-17 20:25:54 UTC 29.8K followers, 5514 engagements

"$NUWE announced the issuance by the U.S Patent and Trademark Office of U.S. Patent No. 12357734 titled "Extracorporeal Blood Filtering Machine and Methods." See More Biotech Updates👇 $SXTP $PMN $ANGO $BCTX $RANI $IKNA $KZR"
@BPharmCatalyst on X 2025-07-15 20:49:05 UTC 29.8K followers, 2991 engagements

"$PMN shares closed up after the company announced that PMN310 its lead therapeutic candidate for Alzheimer's received FDA Fast Track designation. See More Biotech Updates👇 $PMN $ZIMV $EVO $SABS $HOOK $SLRX $CLSD $GDTC"
@BPharmCatalyst on X 2025-07-21 20:58:48 UTC 29.8K followers, 2223 engagements

"BioPharmCatalyst Weekly #Watchlist Key Catalysts Due in Mid-2025 $REPL $OTLK $RARE $WINT $ATAI $CYBN $IXHL $TNXP $VYNE $ATHE $PFE $CRDF $PRAX"
@BPharmCatalyst on X 2025-07-19 15:00:00 UTC 29.8K followers, 6299 engagements

"$TELO reported promising data for Telomir-1 which showed it could reverse epigenetic gene silencing and restore tumor suppressors in human prostate cancer cells outperforming chemotherapy and rapamycin. See More Pre-market Movers 👇 $MESO $CNSP $SRPT $WINT $IINN"
@BPharmCatalyst on X 2025-07-18 12:20:59 UTC 29.8K followers, 2391 engagements

"$MIST received a new PDUFA date of Dec XX 2025 for CARDAMYST nasal spray for PSVT after FDA accepted its CRL resubmission. The company also extended its $75M royalty deal with RTW through year-end. Separately Milestone priced a $52.5M public offering of common and pre-funded warrants at $1.50/share expected to close July XX 2025. See More Biotech Updates👇 $NCNA $INKT $MIST $CAPR $JUNS $PHVS $DARE"
@BPharmCatalyst on X 2025-07-11 20:16:19 UTC 29.8K followers, 6117 engagements